NewtekOne, Inc. (NEWT), a financial services player that’s evolved from a business development company into a full-fledged bank holding company, offers everyday investors a story of transformation amid volatility. Over the past decade, the company has ridden waves of growth fueled by strategic expansions, but it’s also faced headwinds like rising debt and margin squeezes. With revenue ballooning from $31 million in 2016 to $339 million in 2024—a whopping 995% increase—NEWT has scaled up aggressively, particularly after launching Newtek Bank, N.A. in mid-2023. This pivotal move, approved by regulators in June 2023, marked NEWT’s shift to a depository institution, unlocking new lending powers and explaining the employee count exploding from 104 in 2022 to 591 in 2024 (a 468% jump). Yet, as we’ll unpack, the stock price has been a rollercoaster, peaking near 39 in 2021 before dipping to lows around 10 in 2024, now hovering at recent levels that leave room for upside per analysts.

Revenue Growth and Operational Scale-Up

Let’s start with the top line, because revenue is the lifeblood of any growth story—it shows demand for NEWT’s core offerings like SBA loans, banking services, and payment processing. From 2016’s $31 million, sales climbed steadily, hitting $168 million in 2021 (up 344% from 2020 amid pandemic-era lending booms), then dipping to $131 million in 2022 (down 22%) before surging again to $339 million in 2024 (up 25% from 2023’s $271 million). Revenue per employee tells an even sharper tale: skyrocketing from $226,000 in 2016 to $1.38 million in 2021, then normalizing to $573,000 in 2024 as the headcount ballooned post-bank launch. This efficiency drop isn’t alarming—it’s typical for acquisitive phases—but it highlights integration costs.

Analyst forecasts paint a bumpy but upward path: revenue dipping 14% to $292 million in 2025 (perhaps cyclical lending slowdowns or one-offs), rebounding 14% to $332 million in 2026, and another 14% to $377 million in 2027. If realized, this implies steady mid-teens growth, aligning with NEWT’s niche in small business financing. Correlating this to stock performance, highs around 39 in 2021 tracked peak revenue and EPS of $3.69, while 2024’s range (10-15) mirrored softer growth post-expansion. Everyday investors should note: revenue/share has grown from $2.13 in 2016 to a forecasted $13.14 by 2027 (516% total rise), but dilution from share count expansion (14.5 million to 28.7 million shares) tempers per-share gains.

Profitability Shifts and Margin Pressures

Digging into profits, net income has been resilient despite turbulence. It peaked at $84 million in 2021 (up 150% from 2020’s $34 million), crashed 62% to $32 million in 2022 amid higher rates crimping lending, then recovered to $51 million in 2024 (up 7% from 2023). Earnings per share (EPS) followed suit: $3.69 high in 2021 to $1.97 in 2024, with forecasts climbing to $2.46 by 2027 (25% from 2024). EBT margins, a key profitability gauge before taxes and interest (revealing operational health), slid from near-100% pre-2023 to 20.3% in 2024—important because it flags rising costs in banking ops, like funding expenses.

Gross margins stayed perfect at 100% through 2022 (typical for fee-heavy financials), but dropped to 95.7% in 2023 and 92.3% in 2024 (down 3.5 percentage points), likely from loan loss provisions or lower-fee banking products. ROE, which measures how well equity generates profits (crucial for banks), hit 22.6% in 2021 but stabilized at 19.5% in 2024—strong versus peers, signaling efficient capital use. Yet, free cash flow per share remains negative (-$6.15 in 2024), down from a $6.18 positive in 2021, due to heavy working capital swings (from +$170 million in 2021 to -$11 million in 2024). This cash burn correlates with stock weakness, as investors hate funding growth via debt.

Balance Sheet Realities: Debt Surge and Equity Resilience

NEWT’s balance sheet screams “growth mode.” Total debt rocketed from $53 million in 2016 to $1.68 billion in 2024 (3,065% increase!), mostly post-2023 bank formation to fund deposits and loans. Net debt mirrors this at $1.65 billion. Shareholder equity grew too—from $209 million to $296 million (42%)—but lagged debt, pushing PB ratios around 1.15x lately (fairly valued vs. book). ROIC, tracking returns on invested capital, improved to 7.5% in 2024 from negative territory early on, showing better deployment.

This leverage amplifies returns (high ROE) but adds risk—especially in a high-rate world. Recall 2022’s downturn: revenue fell 22%, net income plunged 62%, and stock hit 15 low. Yet, book value/share held steady around $11-17, cushioning downside. Forecasts don’t project debt, but if revenue grows as expected, debt servicing should ease, supporting EPS ramps.

Valuation Snapshot: Cheap on Growth Potential

Valuations look compelling for patient investors. Trailing PE at 6.5x in 2024 (vs. historical 7-12x) screams undervalued relative to EPS growth. PS ratio compressed from 7.6x in 2016 to 0.9x, reflecting scale but also market skepticism on margins. EV/Sales at 5.9x trails earlier peaks, and forecasts dip further (1.4x in 2025), suggesting re-rating upside. Compared to stock price evolution—2021 highs on 7.5x PE amid revenue boom, now lower multiples on similar growth trajectory—NEWT trades like it’s forgotten its bank pivot.

Insider Confidence: A Bullish Vote

Here’s a standout signal: insiders are loading up, with zero sells across 2025-2026 data and buys totaling over $755,000. The CEO (COB, Pres) dominates, snapping up 35,000+ shares in May 2025 alone (costs ~$108k-$116k per tranche) and more into 2026. Directors and execs like CFO, Bank Pres, and HR SVP joined in, buying dips in March, May, August, November, December 2025, and January 2026. No sells? That’s rare conviction—insiders own skin in the game, often preceding 20-50% rallies. Timing aligns with stock lows (~10-15 range), betting on recovery.

Analyst Views and Recent Price Context

Wall Street echoes optimism: average and low price targets sit about 10% above recent closes, while the high target implies nearly 100% upside. This spread reflects base-case steady growth vs. bull scenarios like margin recovery or M&A. Given 2024’s range (low ~10, high ~15) and recent levels, the stock’s down from 2021 peaks but up from 2024 bottoms, loosely tracking revenue/EBITDA turns.

Tying It Together: Risks, Rewards, and Road Ahead

Correlations jump out: revenue/employee peaks drove 2021 stock highs; debt-fueled bank launch boosted scale but pressured cash flow/margins, dragging price to 2024 lows. Yet, forecasts signal inflection—EPS up 12-25% annually through 2027, revenue mid-teens growth—potentially mirroring pre-2021 trajectories if rates ease (Fed cuts post-2024 election cycles could help lending). Major events like the 2023 bank approval (post-SPAC merger in 2021 that took it public) catalyzed scale, but 2022 rate hikes exposed leverage risks.

For retail folks, NEWT’s a high-conviction bet on small-business finance rebound. Insider buying screams “buy the dip,” valuations are dirt-cheap, and growth levers (bank deposits, SBA expansion) position it well. Risks? Debt load (watch net debt/EBITDA), FCF negativity, and 2025 revenue dip could spook markets. But at current multiples, even modest execution yields 20-50% total returns. If you’re diversified, a 2-5% portfolio slice could pay off as this under-the-radar banker re-rates.

(Word count: 1,128)